Levilimab
Levilimab (BCD-089) is a fully humanized anti-interleukin-6 receptor (IL-6R) monoclonal antibody. Levilimab is an inflammation-alleviating antibody. Levilimab can be used for the research of rheumatoid[1].
Product Specifications
CAS Number
[2035008-70-7]
Product Name Alternative
BCD-089
UNSPSC
12352203
Target
Interleukin Related
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/levilimab.html
Purity
98.82
Solubility
10 mM in DMSO
Smiles
[Levilimab]
Molecular Weight
(145.7 kDa)
References & Citations
[1]Pum A, et al. Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm. Biomolecules. 2021 Jan 12;11 (1) :91.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
ELK1341MS-01 48 Tests
Mouse BLC1 (B-Lymphocyte Chemoattractant 1) Microsample ELISA Kit
Ask
View Details ELK1341MS-02 96 Tests
Mouse BLC1 (B-Lymphocyte Chemoattractant 1) Microsample ELISA Kit
Ask
View Details ELK1341MS-03 5x 96 Tests
Mouse BLC1 (B-Lymphocyte Chemoattractant 1) Microsample ELISA Kit
Ask
View Details MBS9924320 Inquire
Pigeon Peroxisome Proliferator Activated Receptor Beta (PPARB) ELISA Kit
Ask
View Details